To elucidate the biological importance of intrahepatic hepatitis D virus antigen, its expression was correlated with biochemical and histological inflammatory activity in 98 biopsy specimens from 68 patients seropositive for total antibody to the virus. Seventy five specimens were positive for intrahepatic nuclear antigen for HDV antigen accompanied by cytoplasmic HDV antigen in only one biopsy specimen. This group had significantly higher serum transaminase activities and inflammatory activity than the remaining cases that were negative for HDV antigen. Among the group positive for HDV antigen, there was no correlation between the proportion of hepatocytes containing HDV antigen and either serum transaminase activity or histological inflammatory indices.
Abstract
To elucidate the biological importance of intrahepatic hepatitis D virus antigen, its expression was correlated with biochemical and histological inflammatory activity in 98 biopsy specimens from 68 patients seropositive for total antibody to the virus. Seventy five specimens were positive for intrahepatic nuclear antigen for HDV antigen accompanied by cytoplasmic HDV antigen in only one biopsy specimen. This group had significantly higher serum transaminase activities and inflammatory activity than the remaining cases that were negative for HDV antigen. Among the group positive for HDV antigen, there was no correlation between the proportion of hepatocytes containing HDV antigen and either serum transaminase activity or histological inflammatory indices.
In 22 HDV antigen positive patients who had follow up biopsy specimens taken at a median of two years, the proportion with cirrhosis increased from 36% to 73%. Serum transaminase activities remained the same during this period, but the proportion of HDV antigen positive cells dropped. Follow up of 51 patients showed that 21 died or underwent liver transplantation within three years.
The absence of an association between intrahepatic HDV antigen expression and progression of histological liver damage does not support the view that HDV is directly cytopathic to hepatocytes. Immune mediated mechanisms may have a role in the pathogenesis of chronic liver disease related to HDV infection. (table 2) . Surprisingly, there was no correlation between serum transaminase activity and the extent of intrahepatic HDV antigen expression (fig 1) .
Intrahepatic HDV antigen expression was also associated with a higher histological activity index (fig 2) . Biopsy specimens positive for intrahepatic HDV antigen had significantly higher histological inflammatory activity scores compared with those without (HDV antigen positive v HDV antigen negative (p < 0-001)) but there was again no correlation between the histological activity scores and the extent of intrahepatic HDV antigen expression. When HDV antigen expression was correlated with individual factors that comprised this histological activity index-that is, portal inflamma- Figure 2 Relation between intrahepatic expression of HDVAg and total histological activity index.
antigen had either died or undergone liver transplantation compared with those with 2 + and 3 + positivity. The four patients with 3 + intrahepatic HDV antigen expression were still alive (two to four years), and in three of them a repeat liver biopsy specimen (median three years) showed a drop in the number of HDV antigen cells ( fig 3B) .
RELATION BETWEEN INTRAHEPATIC HDV ANTIGEN AND HBV MARKERS
Serum HBeAg and HBV DNA were found in eight and six patients, respectively, when they first presented. The HBV replication markers were not correlated with intrahepatic HDV antigen expression. Seven patients seropositive for HBeAg attended follow up; six lost HBeAg and five seroconverted to anti-HBe in a median of two years (range one to four years). All five patients with positive serum HBV DNA who attended follow up lost HBV DNA within three years. A repeat liver biopsy specimen taken in five showed deteriorated liver histology despite loss of HBV replication markers. CORRELATION 
Discussion
Most of the patients with chronic HDV infection in this study had active liver disease on presentation, reflected by the high serum transaminase activity and numbers of inflammatory cells. The high proportion of patients with histological evidence of active cirrhosis on presentation and the five year mortality of around 40% were striking. Although this may in part be related to the fact that our unit is a referral centre, the high histological inflammatory activity index in most patients and the doubling of the proportion of cirrhosis in a median of two years in those HDV antigen positive patients with follow up biopsy specimens confirms the rapidly progressive nature of the disease. The presence of intrahepatic HDV antigen is associated with active liver inflammatory activity, reflected by an increase in the serum transaminase activity and the histological activity scores. In addition to the association between intrahepatic HDV antigen expression and portal inflammation reported previously,4 Recent studies have suggested that host immune factors, in particular T cell mediated immunity, might have an important role in the pathogenesis of liver cell damage in chronic HDV associated chronic liver disease.5 13 The degree of lymphocytic infiltration in the liver, together with the absence of a correlation between the extent of intrahepatic HDV antigen expression and liver inflammatory activities all agree with this hypothesis. This is also supported by the observation that a deterioration in liver histology in follow up biopsy specimens was associated with a decrease in intrahepatic HDV antigen expression, a pattern similar to that observed in chronic HBV infection, which is well known to induce liver damage through immune mediated mechanisms.
The nature of the target viral antigen in chronic HDV infection remains unresolved. Previous studies using immune electron microscopy in a small series showed that most patients had only nuclear HDV antigen." The possibility that treatment with pronase may destroy or remove the cytoplasmic HDV antigen is unlikely because cytoplasmic HDV antigen was shown consistently in most patients in whom HDV recurred after transplantation using the same immunohistochemical techniques (Davis et al, personal communication) . There are several possible alternatives. Firstly, the HDV antigen may have been processed in the hepatocyte cytoplasm so that only T cell epitopes are presented, rendering it a target for T cells but undetectable by immunohistochemical methods which detect only B cell epitopes. Secondly, HDV may mediate liver cell damage through modulation of HBV antigen expression. As reported by others and also in this study, HBV replication and intrahepatic HBcAg expression were suppressed with HDV replication, making nucleocapsid antigens unlikely targets.'4 Finally, chronic HDV infection is associated with autoantibodies and it is therefore possible that active HDV replication may induce the formation of a neoantigen, which in turn may be the target for the T cells.'
Our observation with respect to the suppression of HBV replication by HDV superinfection agrees with previous observations.""'6 It is interesting to note that most patients lost their HBV replication markers within three years, a timing which suggests a suppressive effect of HDV on HBV replication.
